These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17959072)

  • 1. [The clinical characteristics of systemic lupus erythematosus associated with coronary artery disease].
    Dai YX; Zhang SY; DU ZY
    Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):541-3. PubMed ID: 17959072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus?
    Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM
    Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of coronary risk based on cumulative exposure to lipids in systemic lupus erythematosus.
    Nikpour M; Gladman DD; Ibanez D; Harvey PJ; Urowitz MB
    J Rheumatol; 2013 Dec; 40(12):2006-14. PubMed ID: 24128779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus.
    Rahman P; Urowitz MB; Gladman DD; Bruce IN; Genest J
    J Rheumatol; 1999 Nov; 26(11):2363-8. PubMed ID: 10555892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical manifestations of patients with systemic lupus erythematosus and coronary artery disease].
    Qian G; Wang ZF; Liu HB; Chen YD
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):378-81. PubMed ID: 22883086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.
    Bruce IN; Urowitz MB; Gladman DD; Ibañez D; Steiner G
    Arthritis Rheum; 2003 Nov; 48(11):3159-67. PubMed ID: 14613278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in lipid profile between flare and remission of patients with systemic lupus erythematosus: a prospective study.
    Urquizu-Padilla M; Balada E; Chacon P; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 Aug; 36(8):1639-45. PubMed ID: 19531751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in patients with systemic lupus erythematosus: association with traditional risk factors for coronary heart disease and lupus characteristics.
    Telles R; Lanna C; Ferreira G; Ribeiro A
    Lupus; 2010 Jun; 19(7):803-9. PubMed ID: 20118159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.
    Kiani AN; Magder L; Petri M
    J Rheumatol; 2008 Jul; 35(7):1300-6. PubMed ID: 18484694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
    Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosus.
    Orlacchio A; Bruce IN; Rahman P; Kawarai T; Bernardi G; St George-Hyslop PH; Gladman DD; Urowitz MB
    Med Sci Monit; 2008 May; 14(5):CR233-237. PubMed ID: 18443545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
    Ambegaonkar B; Chirovsky D; Tse HF; Lau YK; Tomlinson B; Li SK; Yue CS; Wong TH; Choi MC; Tunggal P; Sazonov V
    Adv Ther; 2012 May; 29(5):427-41. PubMed ID: 22562782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature coronary artery calcification is associated with disease duration and bone mineral density in young female systemic lupus erythematosus patients.
    Ribeiro GG; Bonfá E; Sasdeli Neto R; Abe J; Caparbo VF; Borba EF; Lopes JB; Gebrim E; Pereira RM
    Lupus; 2010 Jan; 19(1):27-33. PubMed ID: 19933722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and coronary features of systemic lupus erythematosus patients with coronary artery disease].
    Yang J; Xu D; Shen ZJ; Wang CH; Zhang SY; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Fang Q
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 May; 40(5):382-5. PubMed ID: 22883087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.
    Borba EF; Bonfá E
    Lupus; 1997; 6(6):533-9. PubMed ID: 9256312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of subclinical myocardial ischaemia in Mexican patients with systemic lupus erythematosus without traditional risk factors for coronary artery disease.
    García-Carrasco M; Escárcega RO; Pérez-Terrón J; Ramírez A; Muñoz-Guarneros M; Beltrán A; Pérez-Cuevas B; López-Colombo A; Cervera R
    Lupus; 2007; 16(4):298-301. PubMed ID: 17439938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha/tumor necrosis factor receptor system in systemic lupus erythematosus.
    Svenungsson E; Gunnarsson I; Fei GZ; Lundberg IE; Klareskog L; Frostegård J
    Arthritis Rheum; 2003 Sep; 48(9):2533-40. PubMed ID: 13130473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.